Close Menu
Aspire Market Guides
  • Home
  • Alternative Investments
  • Cryptocurrency
  • Economics
  • Equity Investments
  • Mutual Funds
  • Real Estate
  • Trading
What's Hot

Property premium of 24% for homes in National Parks

August 31, 2026

Rakebit Launches RakeBears: 1,000 Mystery Box NFTs With

August 31, 2026

Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026

August 31, 2026
Facebook X (Twitter) Instagram
Trending:
  • Property premium of 24% for homes in National Parks
  • Rakebit Launches RakeBears: 1,000 Mystery Box NFTs With
  • Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026
  • DAX on Negative Note – TradingView
  • Bitcoin and Ether ETFs attract $1.75B in inflow…
  • $Walmart (WMT.US)$[Nose Pick] wanted swing trade for coffee money but…. – Moomoo
  • Economic picture less negative in August
  • Wintermute-Linked Wallets Move $399M in Bitcoin to Binance, Fueling Sell-Off Speculation | Bitcoin Market
  • DSP Mutual Fund has declared change in exit load in few schemes
  • Verve Group Media SE: Continued Growth in Q2 2026 Despite Macroeconomic Pressure on Key Advertising Categories and Full-Year Guidance Reaffirmed
Monday, August 31
Facebook X (Twitter) Instagram
Aspire Market Guides
  • Home
  • Alternative Investments
  • Cryptocurrency
  • Economics
  • Equity Investments
  • Mutual Funds
  • Real Estate
  • Trading
Aspire Market Guides
Home»Equity Investments»Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026
Equity Investments

Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026

By CharlotteAugust 31, 20264 Mins Read
Share
Facebook Twitter Pinterest Email Copy Link


This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.



Source link

Related Posts

Equity Investments

DSP Mutual Fund has declared change in exit load in few schemes

August 31, 2026
Equity Investments

Edelweiss vs HSBC vs Invesco vs WhiteOak: How India’s top midcap funds are positioning portfolios

August 31, 2026
Equity Investments

Bybit Launches Equity Perpetual Options With SpaceX and Nvidia as First Markets | Trading derivatives

August 30, 2026
Equity Investments

Nomura Strategic Income Fund Q2 2026 Commentary – Seeking Alpha

August 30, 2026
Equity Investments

Vicor: Strong Growth, But Cash Conversion Remains Unproven (NASDAQ:VICR)

August 30, 2026
Equity Investments

Crescent Capital Group Closes Second CLO Equity Fund at $232MM

August 30, 2026
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Property premium of 24% for homes in National Parks

August 31, 2026

Rakebit Launches RakeBears: 1,000 Mystery Box NFTs With

August 31, 2026

Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026

August 31, 2026

DAX on Negative Note – TradingView

August 31, 2026
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.

Featured

Australian regulator clarifies merger waiver requirements for private equity firms | MLex

June 23, 2026

Bangladesh China Myanmar Connectivity | The Future of the Bangladesh-China-Myanmar Economic Corridor

July 27, 2026

Does Gold Fields (JSE:GFI) Deserve A Spot On Your Watchlist?

May 30, 2026
Monthly Featured

Taiwan lawmaker proposes Bitcoin reserve amid China tensions

May 2, 2026

Modern laws, rising returns drive real estate growth

June 23, 2026

Stablecoin Accounting Gets Close Look as Coins Treated Like Cash

April 15, 2026
Latest Posts

Property premium of 24% for homes in National Parks

August 31, 2026

Rakebit Launches RakeBears: 1,000 Mystery Box NFTs With

August 31, 2026

Cynata Therapeutics Reports $9.09M Net Loss and $897K Cash Balance for FY2026

August 31, 2026
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.

© 2026 Aspire Market Guides.
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Type above and press Enter to search. Press Esc to cancel.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first.

Complete the form below to subscribe to our weekly newsletter.


I consent to being contacted via telephone and/or email and I consent to my data being stored in accordance with European GDPR regulations and agree to the terms of use and privacy policy.